ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Winner of the 2024 PCCA Institute Pharmacy Scholarship, Jennifer Lines, Will Address 500+ Compounders at ThinkNext: International Seminar

Houston, Oct. 14, 2024 (GLOBE NEWSWIRE) -- PCCA has selected pharmacy student Jennifer Lines, PharmD candidate, from The University of Texas at Austin College of Pharmacy, as the winner of the 2024 PCCA Institute Pharmacy Student Scholarship Contest. Lines will deliver a 10-minute mainstage presentation on Saturday, October 19, during ThinkNext: International Seminar 2024. More than 500 compounders from the United States, Canada, Australia and beyond are expected to attend the compounding industry’s biggest event.

“Jennifer is a shining star and the future of compounding,” said PCCA Vice President of Public Affairs, Education and Human Relations Lizzie Harbin. “She recognizes what is needed to make compounding relevant for Gen-Z patients, practitioners and the community.”

A fourth-year pharmacy student earning her doctorate in pharmacy, Lines is also currently serving as a PCCA Clinical Services intern. During her presentation, she will discuss how personalized medicine will accommodate the needs and values of Gen-Z patients and prescribers.

“My generation, ‘Gen-Z,’ is the first truly digital generation. Our whole lives have been shaped by access to unlimited information,” Lines said. “How do we, as compounding pharmacists, break through the endless stream of content? The answer lies between how and where we meet my unique generation.”

Pharmacy students across the country entered the scholarship contest for the opportunity to engage with compounding pharmacists from around the world at ThinkNext. Contest participants were given the option to discuss Advocacy, Innovation or Business Development related to compounding pharmacies. Contest finalists also included Mollie Vergara, a pharmacy student from Northeast Ohio Medical University, and Bo Ewing, a pharmacy student from Lake Erie College of Osteopathic Medicine.

“I am extremely proud of all of our students and their remarkable contest applications,” said PCCA Director of Academic Affairs Bindhu Batra, PharmD, RPh. “This year, we look forward to engaging with even more pharmacy students at our ThinkNext: Student Day on Saturday, October 19, 2024. Students enrolled in a college of pharmacy will have the opportunity to learn more about compounding from our successful pharmacy members and PCCA staff.”

From October 17-19, compounders will converge in Houston and online to inspire and elevate their practices. ThinkNext: International Seminar 2024 attendees will increase their knowledge, discover strategies and gain access to new products and technology via keynotes by industry thought leaders, receive informative talks on new formulations, learn from panels on advocacy and compliance, explore equipment demos and more. For the agenda and registration details, visit pccainternationalseminar.com.

# # #

 

ABOUT PCCA

PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Learn more at pccarx.com.

Attachment


Kim Speairs, APR, MBA
PCCA
817-729-5064
kspeairs@pccarx.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.81
-0.73 (-0.33%)
AAPL  273.04
-1.07 (-0.39%)
AMD  207.56
-0.02 (-0.01%)
BAC  54.89
-0.44 (-0.80%)
GOOG  305.60
-3.72 (-1.20%)
META  653.30
+5.79 (0.89%)
MSFT  474.00
-0.82 (-0.17%)
NVDA  176.15
-0.14 (-0.08%)
ORCL  188.41
+3.49 (1.89%)
TSLA  478.20
+2.89 (0.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.